CUEDC2 ablation enhances the efficacy of mesenchymal stem cells in ameliorating cerebral ischemia/reperfusion insult

Mesenchymal stem cell (MSC) therapy has been reported to be a promising therapeutic option for cerebral ischemia/reperfusion (I/R) insult. However, the poor survival rate of engrafted MSCs under unfavorable cerebral I/R-induced microenvironment inhibits their efficiency during clinical application....

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yan, Xiao, Xia, Xiao, Han, Hu, Zhiping, Tan, Fengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906146/
https://www.ncbi.nlm.nih.gov/pubmed/33494071
http://dx.doi.org/10.18632/aging.202394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906146/
https://www.ncbi.nlm.nih.gov/pubmed/33494071
http://dx.doi.org/10.18632/aging.202394

Ejemplares similares